Skip to content
healthcare.dev

bupropion Hydrochloride

NDC 69097-917, bupropion Hydrochloride, tablet, from CIPLA USA INC.,.

Product NDC
69097-917
Status
Listed
Labeler
CIPLA USA INC.,
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207389
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-917 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE75 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
69097-917-026909709170230 TABLET in 1 BOTTLE (69097-917-02)
69097-917-0769097091707100 TABLET in 1 BOTTLE (69097-917-07)
69097-917-15690970917151000 TABLET in 1 BOTTLE (69097-917-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e4100232-a25d-4468-9057-af7e66205154

Use it

Look up 69097-917 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-917 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-917. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.